This bioresorbable standard-size pill can be interrogated via RFID to confirm it has been taken by the patient.
SAN DIEGO, March 9, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced it will present data from three in vitro dissolution studies exploring the dissolution performance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results